Bomi  Framroze  Holding  AS,  a  close  associate  of  primary insider and Chief
Scientific  Officer Dr. Bomi Framroze in Hofseth Biocare ASA ("HBC"), has on 27
February 2023 purchased 200,000 shares in HBC at a price of NOK 2.69 per share.

Please see the attached notification form for further information.

Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no

This  information is subject to the  disclosure requirements in the Market Abuse
Regulation  EU 596/2014 article 19 number 3 and the Norwegian Securities Trading
Act section 5-12.